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Human DNA repair excision nuclease removes DNA
damage by incising on both sides of the lesion in a pre-
cise manner. The activity requires participation of
16-17 polypeptides. Of these, the XPF·ERCCI complex
and XPG were predicted to carry the nuclease active
sites based on studies with the recombinant proteins
and the yeast homologs of these proteins. Furthermore,
recent work with model (undamaged) substrates have
led to predictions of the roles of these proteins in incis-
ing 5' or 3' to the lesion. We have used damaged DNA
substrates and antibodies to XPG and ERCCI to test
these predictions. Our results reveal that anti-XPG an-
tibodies change the site of 3' incision and at high con-
centration inhibit the 3' incision without significantly
affecting the 5' incision, indicating that XPG makes the
3' incision and further that under this condition 5' inci-
sion can occur without 3' incision. In contrast, anti-
ERCCI antibodies inhibit both the 3' and 5' incisions.
Using a defined system for excision repair we also dem-
onstrate that the 3' incision can occur without the 5'
incision, leading us to conclude that under certain con-
ditions the two incisions can occur independently.
In humans and yeast bulky DNA lesions are removed from
DNA by an ATP-dependent multisubunit enzyme system
which excises 27-29-nt1-Iong oligomers by incising the 3-5th
phosphodiester bonds 3' and the 22-24th phosphodiester
bonds 5' to the lesion (Huang et al., 1992; Reardon et al.,
1993). Of the 16-17 polypeptides required for excision,
studies with the yeast homologs of human proteins
(Prakash et al., 1993; Friedberg et al., 1995) have proposed
two strong candidates for making the dual incisions. RAD2
which is the homolog of XPG is a single-strand specific endo-
nuclease (Habraken et al., 1993). The RAD1·RADlO complex
which is the homolog of XPF'ERCC1 is an endonuclease with
preference for single-stranded and supercoiled DNA
(Tomkinson et al., 1993; Sung et al., 1993). Furthermore,
human XPG protein has been also shown to have single-
strand specific DNA endonuclease activity using recombinant
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protein from baculovirus system (O'Donovan et al., 1994a;
Habraken et al., 1994a).
Recently, model DNA structures have been used with these
proteins in an effort to identify which subunit in the excision
nuclease complex makes which incision. Using partial du-
plexes with single-stranded tails or a flap structure as sub-
strates and a truncated RAD2 protein, Harrington and
Lieber (1994) concluded that RAD2 makes the 3' incision and
suggested that RADl·RADI0 complex makes the 5' nick. In
apparent agreement with this it was found that purified
recombinant XPG protein cleaved the junction of a duplex
with single-stranded arms only in the strand with the 5'
single-stranded tail (O'Donovan et al., 1994b) and the yeast
RADl'RADI0 complex cleaved only the strand with the 3'
single-stranded tail (Bardwell et al., 1994).
However, two recent studies have raised some questions
regarding the roles of these RAD and XP proteins in the dual
incisions of the excinuclease. First, it was found that the RADI
protein alone was capable of incising at the Holliday junction
(Habraken et al., 1994b), revealing that RADI contained the
nuclease active site of the RADl·RADlO complex. Second, it
was also found that RAD2 and XPG possessed 5'~3' exonucle-
ase activity (Habraken et al., 1994c), leading to the suggestion
that scission on the 3' side was made by RADl·RADI0
(XPF'ERCCl) followed by 5' incision by RAD2 (XPG). Further-
more, it was proposed that RAD2 (XPG) digests the excised
oligomer 5' to 3' to create a single-stranded gap necessary for
the helicase functions of RAD3 (XPD) and RAD25 (XPB).
We wished to address the question using the excision assay
of high specificity and sensitivity as well as incision assays and
damaged DNA as substrate. Carrying out experiments with
cell-free extracts (CFEs) and a defined system, and employing
anti-XPG and anti-ERCCI antibodies, lead us to conclude
that in humans XPG makes the 3' and XPF·ERCCI makes the
5' incision. Furthermore, we suggest that in human excinucle-
ase the two incisions can occur independently under certain
conditions.
EXPERIMENTAL PROCEDURES
Materials-HeLa S3 cells were from the stock of Lineberger
Comprehensive Cancer Center (University of North Carolina). Xero-
derma pigmentosum (XP) cell lines used in this study were: XP-A
(GM02345B), XP-B (GM02252A), XP-C (GM02248B), XP-D
(GM02253D), XP-E (CW3), XP-F (GM08437A), and XPG(AG08802 and
GM03021A). The SV40-transformed XP2RO cell line (CW3) was ob-
tained from R. Moses (Oregon State University, Corvallis, OR) via S.
Linn (University ofCalifornia, Berkeley).The XP-Glymphoblastoid cell
line (AG08802) was a gift from K. H. Kraemer (National Institutes of
Health, Bethesda, MD). The other human mutants were purchased
from the National Institute of General Medical Sciences, Human Mu-
tant Cell Repository (Coriell Institute, Camden, NJ). Chinese hamster
ovary mutant cell lines, UV20(ERCC-l), UV4l(ERCC-4=XP-F), and
UVI35(ERCC-5=XP-G), were obtained from the American Type
Culture Collection Repository (Rockville, MD).
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FIG. 1. Substrates for the excision and incision assays. A. internally labeled substrate was assembled from 6 oligomers after 5' labeling of
a cholesterol-containing oligomer (12-mer). For terminally (5' or 3') labeled substrates, two 140-nt-Iong single-stranded oligomers were used and
the 5' end ofthe 140-mer damaged strand contains T in place ofG. B, internally labeled, 3' -labeled, and 5' -labeled substrates were used for excision
assay, 3' and 5' incision assay, respectively. The predicted products after repair reaction with each substrate are shown schematically. The X and
asterisks indicate the positions of cholesterol and the 32p label, respectively.
Amylose resin, T4 polynucleotide kinase, and T4 DNA ligase
were from New England Biolabs. Klenow fragment of Escherichia coli
DNA polymerase I and T4 DNA polymerase were purchased from
Boehringer Mannheim and prestained protein markers were from Life
Technologies, Inc.
XPG and ERCCI Fusion Proteins-We constructed XPG and ERCC1
fusion proteins to produce antibodies. The plasmid pRAD2-synthetic
carrying the human XPG cDNA (Scherly et al., 1993) was kindly pro-
vided by S. G. Clarkson (University of Geneva Medical School). The
XPG in this construct was subcloned into a pMAL-c2 vector (New
England Biolabs) in-frame with malE to obtain pMAL-XPG which over-
produces XPG fused to the maltose-binding protein (MBP). The con-
struction of pMAL-ERCCl has been described previously (Park and
Sancar, 1993). The MBP-XPG and MBP-ERCC1 fusion proteins were
overproduced in E. coli DR153/pMAL-XPG and DH5aF'lacIQ/pMAL-
ERCC1, respectively. The proteins were purified through an amylose
column as described by the manufacturer.
Antibody Production and Immunoblotting-Rabbit polyclonal anti-
XPG and anti-ERCCI antibodies were raised against MBP-XPG and
MBP-ERCC1, respectively, by standard procedures. The anti-XPG an-
tibodies were affinity-purified using a column containing the MBP-XPG
fusion protein immobilized to AminoLink Plus Coupling Gel (Pierce).
The purified antibodies were dialyzed against storage buffer (25 mM
Hepes-KOH, pH 7.9,100 mM KCI, 12 mM MgCI2, 0.5 mM EDTA, 2 mM
dithiothreitol, 17% glycerol) and stored in small aliquots at -20°C.
Immunoblotting was performed by standard procedures.
Substrates-The substrate was a 140-bp duplex containing a choles-
terol attached to a propanediol backbone instead of a nucleoside at
position 70 of the "damaged" strand (Fig. lA). In an extensive survey of
commercially available modified bases and base analogs (including
2-amino-butyl-1,3-propanediol, biotin, and Texas red) we have found
cholesterol-containing DNA (Clontech) to be the best substrate for hu-
man excinuclease. In contrast with other lesions such as thymine
dimer, psoralen monoadduct or acetylaminofluorene-guanine adduct,
this "lesion" is incorporated into a desired sequence by standard
phosphoramidite chemistry and hence is readily available in large
quantities.
Depending on the type of experiment performed we used internally
labeled, 5' -labeled or 3' -labeled substrates (Fig. 1B). Internally labeled
substrate was assembled from 6 oligonucleotides as shown in Fig. lA
(Huang et al., 1994). The 32p label was at the 6th phosphodiester bond
5' to the lesion. The 5'-labeled substrate was prepared by labeling the
140-nt-Iong single-stranded oligomer with the lesion using [1'-32PIATP
and T4 polynucleotide kinase, followed by annealing to the complemen-
tary oligonucleotide. For 3' end-labeling the two 140-nt oligomers were
annealed and incubated with [a-32PldCTP, dATP, and Klenow fragment
of E. coli DNA polymerase I. Filling-in the one nucleotide gap generates
a duplex of 141 bp with blunt ends. The unmodified and cholesterol-
containing oligomers were synthesized by Operon Biotechnologies and
Midland Certified Reagents.
Repair Assays-CFEs prepared by the method of Manley et al. (1980)
or the recently developed reconstituted system (Mu et al., 1995) were
used to measure excision (release of an oligomer containing damage by
dual incisions) or incision (detection of one of the incision sites relative
to the lesion using terminally labeled DNA). The excision assay was
performed as described previously (Huang et al., 1992, 1994). Briefly,
the reaction mixture (25 JLl) contained 32.5 mM Hepes-KOH, pH 7.9, 50
mx KCI, 4.4 mM MgC12' 0.15 mM EDTA, 0.4 mM dithiothreitol, 1.7%
glycerol, 2 mM ATP, 100 JLM of each dNTP, 200 JLg/ml bovine serum
albumin, -1 nM internally labeled substrate, and 50 JLg of CFE. The
mixture was incubated at 30°C for 45 min unless indicated otherwise
and the products were deproteinized, ethanol-precipitated, and resolved
on 10% polyacrylamide sequencing gels. The incision assay was con-
ducted similarly except the substrate was terminally labeled and
dNTPs were omitted. Excision assay with the reconstituted system was
performed by mixing 5 highly purified fractions as described previously
(Mu et al., 1995): MBP-XPA (I), TFIIHlXPG (II), XPC (III), ERCC1·XPF
(IV), and recombinant replication protein A (V). Quantitation of exci-
sion (oligomers in the 23-29-nt range) relative to the recovery of added
substrate was determined by scanning autoradiographs with a Molec-
ular Dynamics Computing Densitometer Series 300 instrument.
Analysis of the Excision Products-The location of cholesterol rela-
tive to the termini of the excised fragment was determined by using the
3' --->5' exonuclease activity of T4 DNA polymerase as described previ-
ously (Huang et al., 1992; Svoboda et al., 1993).
RESULTS
Specificity of Anti-XPG and Anti-ERCCI Antibodies-Since
the effect of antibodies played a central role in our analyses of
the incision reactions, it was important to have high-specificity
antibodies. In fact, antiserum raised against ERCC1 (a-
ERCCl) was of high titer and gave clear signal without prior
purification (Mu et al., 1995). However, since the anti-XPG
serum (a-XPG) showed high background, specific antibodies
were obtained by affinity chromatography. Fig. 2A shows that
of all of the XP cell lines tested only the two XP-G mutants lack
the immunoreactive -180-kDa protein which we identify as
XPG in agreement with highly purified protein preparations
(O'Donovan et al., 1994a; Habraken et al., 1994a). In one XPG
mutant (GM03021A) with residual excision activity (Reardon et
al., 1993), a truncated XPG protein of -140 kDa was reproduc-
ibly detected, although the signal was too faint in this partic-
ular experiment (lane 9). Similarly, a-ERCC1 revealed a spe-
cific band of -40 kDa in all of XP cell lines tested (Fig. 2B)
in agreement with previous reports that ERCC1 does not
correspond to any XP gene (van Duin et al., 1988) or protein
(Reardon et al., 1993). The variability in relative intensity may
be real as in the case of XP-F with low intensity as has been
reported (Biggerstaff et al., 1993) or simply a reflection of the
quality of extract. In any event, Fig. 2 reveals that our a-XPG
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FIG.2. Specific ity of a n ti -XPG a n d a n t i·ERCC l antibodies.
CFEs (100 ILg each) from HeLa (l ane 1) and various XP cell lines (l anes
2-9) as described under "Experimenta l Procedures" were separated by
8% (A ) or 10% (8) SDS-polyac rylamide gel electro phores is an d ana lyzed
by immunoblotting with a-XPG or a -ERCCl, respectively. In experi-
ment A , XP-G CFE prepared from GM0302lA (l ane 9) in addition to
AG08802 (l ane 8) was used. Th e positions of prestained protein marker s
in kDa are indicated .
an d a -ERCC I are of sufficient specificity for use in functional
assays .
Effects of Anti-XPG and Anti-ERCCI Antibodies on Dual
Incisions-To study the roles of XPG an d XPF·ERCCI comp lex
in the du al incisions, we conducted excision assays in th e
presence of eithe r a-XPG or a- ERCC1. Fig. 3A shows a unique
effect of a-XPG on the excision reaction. At low concen tration it
enhances the excision of the 29-mer (7-fold) while having only
mild inhibitory effect (33%) on the overall excision (lane 4); at
higher concen tration the 29-mer becomes a major excision
product concomitant with more pronoun ced overall inhibit ion
(67%) of 23-29-mer excision products (lan e 5). Both effects can
be reversed wit h appropriate amounts of the antigen (lanes 6
an d 7). Excision in the presen ce of a -ERCC I revealed only
inhibition of excision by the antibodies (lan es 8 and 9, 87 and
94%, respectively) which was reversed by addition of recombi-
nant ERCCI (lanes 10 and 11). Th e unusu al effect of a-XPG led
us to investigate these find ings in more detail.
Anti-XP G Antibodies Affect the Site of the 3 ' Incision- The
larger excision fragm en t induced by a-XPG could be due to a
change in the 3' or 5 ' incision site or both . To differ en ti ate
among these possibilit ies we cut out from the gel the 27-mer
maj or excision produ ct and the 29-mer induced by a-XPG and
treated the excised fragments wit h T4 DNA polymerase 3' -'>5'
exonuclease (Fig. 4). Thi s activity is inhibited by lesions in
DNA (Fuchs, 1984). Th e exonuclease treatment generates the
same size fragment (26-mer) from both the 29-mer and the
27-me r (lanes 5 and 7, respect ively). Thus, we conclude that
a-XPG shifts the 3' incision site wit hout affect ing th e site of
5 ' incision. Two possibilities were consid ered for thi s effect .
Either XPG is at the 5 ' incision site and when boun d to anti-
bodies the entire incision complex is disp laced cau sing a change
of incision site by XPF·ERCCI located at th e 3 ' site, or XPG
makes the 3' inci sion an d a subpopulation of th e antibodies
upon binding to XPG do not in hibit th e incision react ion but
disp lace the protein slightly such that th e 5th phosphodiester
bond which is normally attacked by XPG at a low frequ ency
becomes a major target.
We reasoned that looking at th e particular incision sites
under a-XPG inhibitory conditions would help ans wer th ese
questions. Indeed , higher resolution gels reveal that a-XPG, in
addition to the two effect s observed in Fig. 3A, also cau sed th e
appea rance of a 95 nt-long fragment with this internally la-
beled substrate (Fig. 3B). Th is fragment corr esponds to incision
at th e 25th phosphodiester bond 5 ' to th e lesion and hence
re presen ts an "uncoupled" 5 ' incisiorr' (see below). Our poly-
clonal antibodies must have at least two types of antibodies.
One bin ds to XPG and changes its specificity; th e other inhibits
it s functio n an d cause s the excinuclease to ma ke only th e 5'
incision. Ta ken together these data are consistent with XPG
mak ing the 3' inci sion.
Analysis of XPG and XPF ·ERCCI Fun ctions by the 3' Inci-
sion Assay- In this assa y terminally lab eled subst rate was
incubated with th e enzyme system and th e activity was moni-
tored by appearance of ba nds du e to incision 5' or 3' to th e
lesion. Fig . 5 shows the resu lt of such an assay wit h 3'-labeled
substrate. HeLa CFE makes a major incision at the 3rd phos-
phodiester bond 3' to the lesion, an infrequent inci sion at th e
4t h and a moderate level of incis ions at th e 2nd an d 5t h
phosphodiester bond s 3' to the lesion (lane 2) . The incisions are
specific to human excinuclease because th e bands are absent
from DNA treated with CFEs from XP-F (lane 3) and XP-G
(lane 4) mu tants and can be restored by mixing th e two mutant
extracts (lan e 5). Th is conclu sion is further supported by sim-
ilar assays with Chinese hamster ovary excision repair mu-
tants. UV20 (ERCC-l) (lane 6), UV41 (XP-F) (lane 7), and
UV135 (XP-G) (lane 8) do not show 3' incision consi stent with
lack of excis ion (Reardon et al ., 1993) and re pa ir synthesis
(O'Donovan and Wood, 1993) by these mutants. Furthermore,
CFEs of ERCC-l and ERCC-4 (XP-F) mutants fail to comple-
men t in th e incisio n assay (lane 9), consistent with th e conclu-
sions that the se two proteins are in a tight complex which does
not exchange subunits readily in vitro (Reardon et al ., 1993). In
contrast, CFEs ofUV20 plus UV135 and UV41 plus UV135 do
complement (lan es 10 and 11, respect ively). In th ese latter two
the 3 ' incision occurs with about equ al freq uency at the 3rd and
5t h phosphodies ter bonds.
Having th us shown that the 3 ' incision can be detected in
this as say with 3 '-labeled DNA, we wished to confirm the
observations we made wit h the internally labeled subst ra te
using the 3 ' incision assay. Fig. 6 shows th e resu lt s of such an
assay. The a-XPG has two specific effect s in addition to overall
inhibit ion of 3' incision (lanes 5 an d 6, 71 and 88% inhibition,
res pectively): first , they reverse the freq uency of incisions at
the 3rd and 5t h phosph odiester bonds 3' to the lesion (lane 5,
rati o of incis ions is 1 to 1.7) compared to th e control (lane I ,
rat io of 1 to 0.4); second, they give ri se to a band at position 96
(corresponding to posit ion 95 in th e 140-bp subs trates) which
can only be generated from a 5' inci sion uncoupled from 3'
incisio n (Fig. lB). These result s a re consistent with th e data
obtained wit h the internally lab eled subst ra te. In contrast,
a-ERCCI inhibits 3' incision entirely but does not produce th e
2 Uncoupl ed 5' or 3' incisions refer , res pectively, to reactions in which
th e excinuclease makes the 5' incision but fails to mak e th e 3' incision
or vice versa.
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FIG. 3. Effects of a nti -XPG and a nt i-
E RC C I antibod ie s on d u al incis ions.
A, th e indi cated amounts of antibodies
(A b), preimmune, a -XPG, or a-ERCCI
were preincubated (for 10 min on ice) with
HeLa CFE (50 Jlg ) in th e abse nce tlanes
1-5, 8 , and 9) or presence of antigen (Ag),
MBP-XPG ilanes 6 and 7), or ~IBP 
ERCC1 ilanes 10 and 1J), and th en added
to th e reacti on mixtures containing th e
internally labeled subst ra te (l 40-bp). The
excision products were resolved on a 10%
polyacrylamide sequencing gel and th e
positions of th e subst ra te (l 40-mer ) and
th e products (27- and 29-mers) ar e ind i-
cat ed. B, th e excision products were re-
solved on a 10% polyacrylamide seque nc-
ing gel for longe r period s to increa se th e
resolution of la rger fragm ents. Two Jll of
a-XPG were used (lan e 3) and th e posi-
tions of DNA size marker s (ebX I74IHinll)
are indica ted in th e left mar gin . Right
pan el , schemat ic drawings of th e incision
pattern of human excinuclease on th e in-
ternally lab eled 140-bp substra te. In th e
ab sence of antibodies, 7.1% of the dam age
was excised as det ermined by th e inten-
sity of th e bands.
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FIG. 4. Perturbatio n of the 3 ' inc is ion s ite by a n t i-XPG a n t i-
bod ies, After excision rea ction with HeLa CFE in the presence of
a -XPG, th e produ cts were sepa ra ted on a 10% polyacrylamide sequenc-
ing gel, and th e 27-mer major excision product and the 29-mer ind uced
by a-XPG were cut out from th e gel. The eluted products were resolved
on a 10% polyacrylamide sequencing gel untreated (lanes 4 and 6) or
afte r treatment with T4 DNA polymer ase 3'-5' exonuclease (lanes 5
and 7). For comparison , th e products from excis ion reaction without
ilane 2 ) or with (lane 3) a -XPG (I ul ) were also exa mined. The positions
of th e markers (30-mer) and th e produ cts (26-, 27-, an d 29-mers) a re
indicated. The excised fragm ents containing a cholesterol molecu le
migrate 1 nt s lower than unmodified DNA of the same length (see
Fig. 6).
uncoupl ed 5' incision, indicating that a -ERCC1 possibly inhib-
its 5 ' incision as well. Furth er experiments were conducted
with 5' -labeled subst rate to ascertain our conclus ions regard-
ing th e roles of XPG and XPF·ERCC1 on 5' incision .
Incision Assay with 5' -Labeled DNA -In Fig. 7 we show th at
HeLa CFE mak es seve ra l incis ions centered a round th e inci -
sion at th e 25th phosph odiester bond 5 ' to the lesion (lane 3 ).
These bands are not produced by XP-F (lane 4) or XP-G (lane 5 )
extracts and the activity is restored by mixing the two extra cts
(lane 6). Mutan t Chinese ham ster ovary cell lines UV20
(ERCC-l ), UV41 (XP-F), and UV135 (XP-G) are also defective
in 5 ' incision (lanes 7- 9), and th e combin ation of UV20 + UV41
again fails to restore th e activity (lane 10 ) but UV20 + UV135
and UV41 + UV135 combinations show complementa tion of
the inci sion activity (lanes 11 an d 12). These results taken
together with t hose in Fig. 5 rev eal that the lack of excision
(Reardon et al ., 1993) and repair synthesis (O'Donovan and
Wood, 1993) is du e to th e lack of both 3 ' an d 5 ' incisions in the
mutant cell lines. In addition , we could not detect an y (uncou-
pled ) 3 ' and 5 ' incisions in all oth er XP mutan t CFEs used in
this study."
Having establis hed a 5' incis ion assay, we then investigated
the effects of anti bodies on the 5 ' incision. Fig. 8 shows that
a-XPG inhibits 5 ' incisio n only modera tely (lanes 5 and 6, 6 and
53% inh ibit ion, respect ively) compared to the control preim-
mune se ru m (lanes 3 and 4, 4 and 21%, respectively), whereas
a -ERCC1 inhibits the 5 ' incision as efficiently as the 3 ' incis ion
(lanes 7 and 8 , 69 and 80%, respectively). Hence, we conclude
that a subse t of a -XPG inhibits the 3 ' incision but not th e 5 '
incision, while a -ERCCI inhibits both the 3 ' and 5' incisions.
Our dat a up to this point st rongly suggest that XPG makes th e
3' incision an d XPF (in th e form of XPF·ERCC1 complex)
mak es the 5' incision and further th at th e 5' incision can occur
wit hout th e 3' incision. Th e inhibition of both 5 ' an d 3' incision
by a- ERCCI could be by two mechanisms. First, th e 5' incision
is mad e ini tially and inhibition of this incision indirectly pre-
vents 3' incision; second, the XPF·ERCCI complex is esse nt ial
for th e assembly of th e excinuclease complex an d prevention of
binding of XPF·ERC CI to the oth er subunits of th e excinucle-
" T. Matsunaga and A. Sancar, unpubl ished results .
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FIG. 5. Inci si on assay with 3 '-la bele d subst r ate (3' incision
assay). Fi fty p.g of HeLa CFE (lane 2 ) or mutant CFEs (lanes 3, 4 and
6-8) were incubated wit h 3' en d-labe led su bstrate at 30 °C for 60 min.
In complementation reactions (lan es 5 an d 9 - 11), 25 p.g from each cell
line was prem ixed and then added to the reaction mixture . Th e products
were reso lved by electrophoresis on a 10% polyacrylam ide seque ncing
gel. Lan e 1 shows th e Maxam -Gilbert reaction of G+A. The arrow an d
triangles indica te the major 3' incisio n site. The posit ion of th e sub-
strate 041-mer) is also indicated. As determined by the intens ity of th e
ba nds rela tive to th e total amount of the DNA, 9.3% of th e total
ra dioac tivi ty was detected in the 67-70-nt region with HeLa CFE (lane
2 ), in contrast to 0.2- 0.8% (background) with mu tant CFEs (lanes 3, 4,
and 6-8). In complementation reactions (lanes 5, 10, and 11), 4.8-5.6%
of that was det ected in th is region ti.e. ap proxima tely 50-60% compl e-
ment ation). CHO, Chinese ham ster ova ry.
ase res ults in complet e inhibition of any nicking activity.
Order of Incisions-In E. coli (A)BC excinuclease the UvrB
mak es th e 3' incision and th en UvrC makes the 5 ' nick (Lin et
al., 1992). If UvrB fail s to mak e the 3' incision UvrC cannot
incise 5 ' even when it is bound to the UvrB·DNA complex (Lin
and Sa ncar, 1992 ). The total lack of both 3' and 5 ' nicking
act ivity in XP-F a nd ERCC-l mu tants a nd th e proportional
inhibition of both nicking by a -ERCC I but not by a -XPG com-
bin ed with th e observation of un coupl ed 5' incision in the
presence of a -XPG (Figs. 5-8) suggested that th e opposite may
be the case in human s: 5' incision mu st be mad e by
XPF·ERCCI before XPG can inci se at the 3' side . Thi s model
would exclude th e production of 3 ' unc oupl ed nicks. In fact , we
have never obse rved th e bands corresponding to th e 3' uncou-
pled nick s in th e HeLa CFE sys tem. However, in a highly
defin ed system which we have recently esta blished (Mu et al .,
1995), a band (72-mer ) gene ra te d by th e possibl e u ncoupled 3'
incision was ofte n det ected . Fig. 9A shows th at excision is
accompanied by th e appea ra nce of a 72-n t-Iong fra gment only
when all 5 fractions were used (lane 2) , indicating th at th e
production of the 72-mer is specific to huma n excinuclease
FIG. 6. Effec ts of a n t i·XPG a n d anti·ERCCI a n ti bodies on the
3' inci sion. HeLa CFE (50 p.g) was preincubated (for 10 min on ice)
with th e indicated amounts of antibodies (Ab) , preimmune (lanes 2 and
3), a -XPG (lanes 5 and 6), or a- ERCCI (lanes 7 and 8), and th en added
to the reaction mixture conta ining 3' end-labeled substrate (30 °C, 60
min ). The produ cts were reso lved by elect rophores is on a 10% polyacryl-
amide seque ncing gel. Lan e 4 shows th e Maxam-Gilbert reaction of
G+A. The closed arrows and tr iangles indica te the major 3' incis ion
sites and th e open arrows and tria ngles indicate the un coupl ed 5'
incision site. Th e position of th e substrate 04 1-mer) is a lso indicated.
activity. To confirm th e specificity of thi s nick th e excision
reaction was performed in th e presence of a -XPG. Fig. 9B
shows that th e antibodies specifically inhibit th e appearance of
the 72-mer fragment in addition to excised frag ments (23- 27-
mers) by dual incision s whi le simultaneous ly enhancing th e
inten sity of bands in the 91-96-mer region . Th ese data are
consistent with a-XPG inhibiting 3 ' incision (72-mer) and ex-
cision (23- 27-mers) without sign ificant ly affecting th e 5' inci-
sion. Thus, we conclude that th e 72-mer band arose from un-
coupled 3' inci sion and th at in humans 3 ' an d 5' incisions can
occur ind ependent of one another under certain conditions.
DISCUSSION
Nucleotide excision repair, in gene ra l, is simila r in E. coli
and humans: a rnulti subunit-A'I'P depend ent enzyme sys te m
removes damage by a dual incision mechan ism . However , th ere
are no sequence homologi es betw een th e proteins involved in
th e two sys tems. Furthermore, whereas a t least 16 polypep-
tid es are required for du al incis ions in human s (Mu et al .,
1995 ), in E. coli 3 subunits are necessary and sufficient for dual
inci sion s (Grossma n and Thi agalingam , 1993; Sanc ar, 1994).
In contrast to th e differences betw een E. coli and humans, it
appea rs th at th e excision repair sys te ms in Saccharomyces
cereuisiae and human s are very simila r in all as pects including
number and sequences of protein s in volved (Pra kash et al .,
1993; Fri edberg et al., 1995). Hence the discovery that yeast
RAD2 protein (XPG homolog) had single-st ra nd specific endo-
nucl ease activity (Habraken et al., 1993) and a lso acted as a
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FIG. 7. Inci si on assay w it h 5 ' · la beled s u bstrate (5 ' inclslon
assay). Fi fty Jig of HeLa CFE (lan e 3 ) or mutant CFEs (lanes 4, 5, and
7- 9) were incubated wit h 5' end-labeled subst ra te a t 23 °C (to reduce
nons pecific degr adation) for 60 min. In compleme ntation reactions
(lanes 6 a nd 10-1 2 ), 25 Jig from eac h cell line was pr emixed and th en
added to the reaction mixture. Th e products wer e resolved by electro-
phore sis on a 10% polyacryla mide seque ncing gel. Th e pr odu cts of PuuII
restriction digesti on (lan e 1) an d the Maxam -Gilbert reaction of G +A
(lane 2 ) were used for determin ing the incisio n si tes. Th e closed arrow
a nd tria ngles indicate the majo r 5 ' incision si te in human CFE a nd th e
open arrow a nd triangles ind icate that in Chi nese ham st er ovary W HO)
CFE. Th e posit ion of the subs trate (l40-mer) is also indicate d. As
determine d by th e inte ns ity of th e bands relative to the total a mount of
the DNA. 9.8% of th e tota l ra dioactivity was detected in the 44-49-nt
regio n with HeLa CFE (lan e 3 ). in contras t to 1.6 - 2.2% (backgr ou nd)
with mutant CFEs (lan es 4, 5, a nd 7-9). In compleme nta tio n reacti ons
(lanes 6, 11, a nd 12 ), 3.7-5. 1% of that was det ected in this regio n (i.e.
approxima tely 37- 52% compleme ntation ).
5 '->3' exonuclease (Harrington and Lieber, 1994; Habrak en et
al ., 1994c ) is relevant to the human sys tem. Ind eed, XPO ha s
both act ivit ies (O'Donovan et al ., 1994a ; Habraken et al ., 1994a ,
1994c). Similarly, th e XPF·ERCCI comp lex which is the puta-
t ive homolog of th e RADl·RADIO endonuclease is expecte d to
be an endonuclease (Tomkinson et al ., 1993; Sung et al. , 1993).
Since in E. coli UvrB has th e 3 ' incision act ivity and UvrC
makes th e 5 ' incision (Lin and Sanc ar, 1992; Lin et al. , 1992 ),
the discovery of endonuclease act ivit ies in RAD2 and RADl ·
RADIO led to th e expecta t ion th at each of th ese nucl eases
made one of the inci sions. Recent work with model subst ra tes
has led to specific predictions. Thus it was found that a trun-
cated RAD2 incised a DNA with a single-stra nded flap only
whe n th e flap had a 5 ' terminus, leading to th e pre diction
that RAD2 a nd th erefore XPO mu st make the 3 ' incision
(Ha rri ngto n and Lieber , 1994 ). A study with V-shaped DNA
and recombinant XPO protein also found that only th e strand
with 5 ' sing le-stranded te rminus was nicked and furthermore,
tha t a DNA with a single-stra nded bubble was nicked at the 3'
FIG. 8. Effects of a n t i-Xl- G and anti·ERCCl antibodies on the
5 ' incision. HeLa CFE (50 Jig ) was pr eincubated (for 10 min on ice)
with th e indicated amounts of a ntibodies (Ab). pr eimmune (lanes 3 a nd
4), a -XPG (lanes 5 a nd 6), or a -ERCC I (lanes 7 a nd 8 ). and th en added
to the reacti on mixture containing 5' end-labe led subs tra te (23 "C, 60
min ). The produ cts wer e resolved by electrophores is on a 10% polyacryl -
amide seque ncing gel. Lane 1 shows th e Maxam -Gilbert reaction of
G+A. Th e arrows indicate th e 5 ' inci sion site s.
end of the bubble in the par ticular strand analyzed (O'Donovan
et al ., 1994b) leading to the conclusion that XPO must mak e th e
3 ' incision. On the other hand, studies with RADl·RADIO
complex and forked DNA showed that th e strand with 3' single-
stranded terminus was nicked at the junction with th e double-
st randed region (Bardwell et al ., 1994) and hence it was sug-
gested that RADl·RADI0 (and XPF ·ERCCl) must mak e th e 5'
incision . However, an alternative model was advanced based on
the finding that both XPO a nd RAD2 have intrinsic 5'->3'
exonuclease activity; it was, th erefore, sugges ted th at thi s find-
ing was consistent with XPO making th e 5' incision an d then
partially degrading th e excised oligomer to enable helicases to
displace the excision product (Habraken et al ., 1994c). Two
other observations are consistent with thi s model. First, th e
excision gap is not enlarge d from th e 3' incision site (Huang et
al ., 1992 ); second , the excised oligomer is degraded in 5'->3 '
direction in CFE (Svoboda et al ., 1993). Hence , even thou gh
studies with model sys te ms have been highly informative, th ey
are not conclusive. Experiments with damaged substr ates are
needed to assign the roles of XPO an d XPF·ERCCI in the two
inci sion reactions. In the present study, we us ed the excision
and incision assays with damaged DNA and specific antibodies
for the incision enzymes, an d demonstrated that XPO makes a
major incision at th e 3rd phosphodiester bond 3 ' to the lesion
and XPF·ERCC I complex inci ses mainly at th e 25th phosphodi-
ester bond 5 ' to the lesion .
Two reports in the literature deal with substrates containing
DNA lesions and CFE s from mutant cell lines to analyze roles
of the subunits on incision reaction. In one, it was shown th at
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FIG. 9. Effects of anti -XPG nntibod-
ies o n t h e r econstituted excision re-
pair system. A: lan e 1, Fractions I-IY;
lan e 2, Fractions I-Y; la ne 3, Fraction Y
(re plicat ion protein A, RPA ) alon e. Th e
excision reaction with the internally la-
beled substra te (140-bp) was ca rried out
as described under "Experimenta l Proce-
dures" except th at dNTPs wer e omitted .
Th e product s wer e resolved by elect ro-
phoresis on a 10% polyacrylamide se-
quencing gel. Th e positions of DNA size
markers (<bX I 74IHi ll ll and q,X1741HaeIII )
a re indicated on th e left margin . Th e
closed a nd open arrows show th e major
excision product (27-mer ) a nd th e novel
band (72-mer) observed in lane 2, respec-
tively. B, n-XPG (l Ill) was added to the
mixture of Fractions I-Y and preincu-
bated (for 10 min on ice). The a na lysis of
excision products wa s carried out as de-
scribed in A . Th e positions of DNA size
marker's (<bX I 74IH i ll l1) and th e excision
products (27- a nd 29-mers) a re indicated .
Right panel , sche ma tic drawings of th e
inci sion pattern of human excinuclease on
th e inte rnally labeled 140-bp subst ra te.
A
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CFE s from XP-C, -0 , an d -G incised weakly a t the 3rd phos-
phodiester bond 3' to a single thymine dimer (Tateishi et al .,
1993), lea ding one to suspect that perhaps these subunits were
not nee ded for 3' incision. Th e other report presen ted data
showi ng an incision by HeLa CFE at about 420 nt from th e 3 '
end of a fragment which contained a GTG-cispla t in adduct a t
posit ion 424 . It was also stated that extract from an ERCC-1
mutant cell line (43- 3B) incise d weakly at this position
whereas CFE from an XP-G cell line showed little or no dam-
age -dependent incision at this position (O'Donovan et al.,
1994b), suggesting that XPG but not ERCC1 was needed for 3'
incision . These contradictory resu lts can be reconciled by as -
suming that the "incisio ns" detected in these types of experi-
ments may sometimes be the products of nonspecific 3'-5 ' or
5 '- 3 ' exon ucleases which degrad e DNA starting from an end
Or a nonspecific nick in the substrate. Most such nucleases are
blocked by lesions eithe r at the lesion site Or 1 to 2 nucl eot ides
prior to the lesion giving the appea rance of a specific nick .
Ind eed such an effect is see n in our Figs. 5 and 7. Th is phe-
nomenon is not uniq ue to a part icular cell line; it shows con-
siderable variability between extracts from th e same cell line.
In this paper, we show that the incisions are specific to exc-
inuclease activity based on the complementa t ion experiments
an d specific inhibit ion by the re leva nt antibodies .
The second mechanistically significant find ing of our work
deals wit h the order of incision. In E. coli if UvrB (because of
acti ve site muta tion ) is un ab le to ma ke the 3 ' incision, UvrC
fails to make the 5 ' incis ion. On the oth er hand if active-s ite
mu ta nt UvrB is load ed onto dam aged 0 A containing th e 3 '
incision , addition ofUvrC to the UvrB-preincised DNA complex
leads to quan titat ive 5 ' incision and hence excision. In contrast ,
when active site mu tan t UvrC binds to UvrB·DNA complex,
UvrB does mak e (uncoupled) 3 ' incis ion quantitati vely. Thus, it
was concluded th at in UvrB·UvrC·DNA complex produ ction of
3' incision by UvrB lead s to a conforma tiona l change in th e
complex ena bling UvrC to mak e the 5' incision (Lin et al.,
1992). Th e inhibition of both 3' and 5' incis ions by a- ERCC1
and th e det ectability of un coupl ed 5' incisio n in our experi-
men ts led us to sus pect that in human excin uclease also the re
was a n order of incision with 5 ' precedi ng the 3' incision.
However, furth er experiments wit h the defined system re-
veal ed th e presen ce of un coupl ed 3 ' incision (Fig. 9). Thus it
is possibl e that in human s as well 3 ' incision pr ecedes 5 '
incisio n, but that in th e presen ce of a-XPG th e enzy me sys-
te m is induced to mak e 5 ' incision only. Wheth er un coupl ed
5 ' in cision occurs at all in the abse nce of a ntibodies re ma ins
to be determined .
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